Perspectives on Cannabis
49 total results. Page 1 of 2.
Counsel Brian Malkin will speak on a panel about FDA’s role in the regulation of cannabis at the Food and Drug Law Institute Legal and Practical Issues in the Evolving World of Cannabis Regulation conference on November 18-19, 2019.
Restaurant CBD Sales are Booming, but New Liability Concerns Keep Cannabis Producers from Cashing In
Arent Fox Associate Emily Leongini was quoted in the Hemp Industry Daily article, “Restaurant CBD sales are booming, but new liability concerns keep cannabis producers from cashing in,” published on June 10, 2019.
Arent Fox Associate Emily Leongini was quoted in the Atlanta Journal-Constitution article, “Confusion continues over the legality of CBD products,” published on May 31, 2019.
Arent Fox Associate Emily Leongini was quoted in the Hemp Industry Daily article, “Five things CBD insiders are looking for from the FDA,” published on May 21, 2019.
Last week, USDA’s Agricultural Marketing Service convened a webinar to accept public comments on implementing the hemp provisions included in the 2018 farm bill.
While he did not use a hemp pen like the one used by Senate Majority Leader Mitch McConnell (R-KY) to sign the conference report, President Trump signed into law the 2018 farm bill that includes a provision that legalizes hemp. Specifically, the provision would remove hemp from the federal list of c
With only two months until the January 1 implementation of the final State Cannabis Regulations, the California agencies given licensing authority under the Medicinal and Adult-use Cannabis Regulation and Safety Act posted last minute changes that are causing quite a buzz in the cannabis community.
On October 17, 2018, Canada celebrated Legalization Day – an event marking the end of a prohibition against recreational cannabis use.
Last week, the FDA confirmed it conducted a surprise inspection of e-cigarette manufacture Juul Labs.
Last week, the Drug Enforcement Agency (DEA) published in the Federal Register its Final Order placing FDA-approved cannabidiol drug products (CBD) containing no more than 0.1 percent tetrahydrocannabinols in schedule V of the Controlled Substances Act.
US Customs and Border Protection’s Executive Assistant Commissioner of Field Operations, Todd Owen, recently spoke with Politico and confirmed that CBP will continue to apply long-standing US federal laws and regulations that treat marijuana as a banned substance at the US border.
California recently announced policy drawing lines between permitted and prohibited sources of cannabinol in products intended to be eaten.
The association between the alcohol beverage and cannabis industries continues to grow. Dan O'Neill, a former CEO of Molson Brewery and past senior executive at Campbell Soup Company and H.J. Heinz, has recently joined the board of CannaRoyalty.
On May 22, 2018, the New York State Bar Association’s Committee on Cannabis Law held its inaugural legislative CLE program.
Canadian cannabis producer, Hydropothecary, announced on April 11, 2018 that it had signed a five-year deal to supply the Société des alcools du Québec (SAQ), a Quebec Provincial Crown Corporation, with cannabis for distribution to consumers, once marijuana legalization takes effect later this year.
Canadian cannabis producer, Hydropothecary, announced on April 11, 2018 that it had signed a five-year deal to supply the Société des alcools du Québec (SAQ), a Quebec Provincial Crown Corporation, with cannabis for distribution to consumers, once marijuana legalization takes effect later this year.
Last October, we alerted you that watchdog groups were filing notices of violation (NOVs) against cannabis dispensaries for alleged violations under Proposition 65.
The 9th Circuit Court of Appeals in San Francisco heard oral arguments regarding the Hemp Industry Association’s petition challenging the US Drug Enforcement Administration’s rule that designates “marihuana extracts,” including those with cannabidiol as Schedule I controlled drug substances.
As we reported in October 2017, marijuana dispensaries represent the latest wave of Proposition 65 targets.
On January 4, 2017, Attorney General Jeff Sessions announced the rescission of an Obama-era Department of Justice guidance known as the “Cole Memo” that provided guidelines for the federal enforcement of state-compliant marijuana possession and regulation of marijuana production.
The New York State Bar Association (NYSBA) has approved of the creation of a new Cannabis Law Committee, which will study and recommend measures—including legislation and administrative action—regarding a number of topics related to cannabis.
Last week, Tarukino, Inc., a Seattle, WA based beverage company, announced the launch of six cannabis-infused beverage products, which the Washington State Liquor Control Board had recently approved for marketing in the state.
California agencies posted their proposed emergency regulations for commercial medicinal and adult-use cannabis.
The US Food and Drug Administration recently issued warning letters to four companies.
It has been widely reported that Constellation Brands has acquired a 9.9% interest in Canopy Growth Corp., a Canadian vendor of marijuana products. This is the first foray by a major supplier of alcohol beverages in this area.